journal article·2025-07-15

Metal Armor-Decorated Neutrophil Micromotors with Self-Propelled and Targeting Function for Brain Injury Precise Therapy

Dingxuan Lan, Heping Wang, Dianyu Wang, Shuxiang Wang, Jiayu Mi, Han Gui, Xiaoyao Cai, Yi Xia, Huirong Fan, Hongmei Cao, Jianfeng Liu

ACS Nano· Volume 19· Issue 27
Publisher page

Abstract

Radiation-induced brain injury (RIBI) is a common brain injury following radiotherapy to the head and neck region, which is often accompanied by severe cognitive dysfunction, seriously affecting the quality of life of patients. Studies have established that excessive free radicals produced by radiation are mainly responsible for RIBI. However, there are currently no clinically effective drugs for RIBI treatment. Although nanocatalyst-mediated catalytic therapy is a powerful tool for the treatment of oxidative damage, it is limited by poor targeting and the blood-brain barrier (BBB). Herein, we develop metal armor-decorated neutrophil micromotors (Neumotor) to achieve brain targeting and penetration, which are composed of cryo-shocked neutrophils (CS-Neu) retaining cell membrane integrity and possessing high expression of cell adhesion molecules and chemokine receptors due to a pretreatment strategy, surface thioketal-linked platinum nanoclusters (PtNCs) with catalytic activity. Notably, Neumotor preserves the inflammation-targeting capability of neutrophils and additionally exhibits multienzyme-mimicking activity, reactive oxygen species-responsive release of PtNCs, and self-propulsive functions. Thus, the Neumotor effectively achieves brain targeting and penetration, neutralizes irradiation-caused excess free radicals, mitigates inflammatory damage, BBB disruption, and neuronal injury, ultimately ameliorating cognitive, memory, and spatial perception deficits in RIBI mice. This study not only presents a distinct application for neutrophils but also proposes a feasible catalytic therapy strategy for RIBI.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Tianjin Institutes of Health Science, Institute of Radiation Medicine

Chinese Academy of Medical Sciences & Peking Union Medical College

Funding

China Postdoctoral Science Foundation · Tianjin Municipal Science and Technology Committee · National Science Fund for Distinguished Young Scholars · National Natural Science Foundation of China · CAMS Innovation Fund for Medical Sciences

References (61)

Show source-provided references
1. 10.1038/s41569-024-01056-410.1038/s41569-024-01056-4 ↗
2. 10.1016/j.freeradbiomed.2024.04.21910.1016/j.freeradbiomed.2024.04.219 ↗
3. 10.1111/bjh.1613810.1111/bjh.16138 ↗
4. 10.1126/science.abg236510.1126/science.abg2365 ↗
5. 10.1038/s41467-023-42665-w10.1038/s41467-023-42665-w ↗
6. 10.1016/j.drudis.2020.10.00310.1016/j.drudis.2020.10.003 ↗
7. 10.1016/j.biopha.2022.11414210.1016/j.biopha.2022.114142 ↗
8. 10.1186/s12974-022-02596-710.1186/s12974-022-02596-7 ↗
9. 10.1158/0008-5472.CAN-20-159910.1158/0008-5472.CAN-20-1599 ↗
10. 10.1016/j.neuroscience.2023.10.01710.1016/j.neuroscience.2023.10.017 ↗
11. 10.1007/s12035-023-03831-910.1007/s12035-023-03831-9 ↗
12. 10.1126/scitranslmed.abm654310.1126/scitranslmed.abm6543 ↗
13. 10.1038/nrc173510.1038/nrc1735 ↗
14. 10.1016/j.jenvrad.2020.10637510.1016/j.jenvrad.2020.106375 ↗
15. 10.1111/mmi.1520810.1111/mmi.15208 ↗
16. 10.1021/acs.molpharmaceut.3c0060010.1021/acs.molpharmaceut.3c00600 ↗
17. 10.1016/j.biomaterials.2024.12286810.1016/j.biomaterials.2024.122868 ↗
18. 10.1002/adma.20220677910.1002/adma.202206779 ↗
19. 10.1038/s41467-022-29772-w10.1038/s41467-022-29772-w ↗
20. 10.1002/adfm.20210566210.1002/adfm.202105662 ↗
21. 10.1038/s41573-022-00476-610.1038/s41573-022-00476-6 ↗
22. 10.1002/adfm.20210008810.1002/adfm.202100088 ↗
23. 10.1002/exp.2021010610.1002/exp.20210106 ↗
24. 10.1016/j.addr.2023.11484010.1016/j.addr.2023.114840 ↗
25. 10.1002/anie.20230108310.1002/anie.202301083 ↗
26. 10.1038/s41467-022-29672-z10.1038/s41467-022-29672-z ↗
27. 10.1002/adma.20200240610.1002/adma.202002406 ↗
28. 10.1016/j.immuni.2021.06.00610.1016/j.immuni.2021.06.006 ↗
29. 10.1038/s41565-018-0254-410.1038/s41565-018-0254-4 ↗
30. 10.1038/nnano.2017.5410.1038/nnano.2017.54 ↗
31. 10.1002/adma.20231166110.1002/adma.202311661 ↗
32. 10.3389/fimmu.2012.0015710.3389/fimmu.2012.00157 ↗
33. 10.1158/0008-5472.CAN-14-309510.1158/0008-5472.CAN-14-3095 ↗
34. 10.1021/acs.nanolett.9b0375310.1021/acs.nanolett.9b03753 ↗
35. 10.1021/acsnano.3c1269410.1021/acsnano.3c12694 ↗
36. 10.1126/scirobotics.aba613710.1126/scirobotics.aba6137 ↗
37. 10.1016/j.jcis.2023.12.09110.1016/j.jcis.2023.12.091 ↗
38. 10.1242/jcs.26076810.1242/jcs.260768 ↗
39. 10.1142/S233954781350004010.1142/S2339547813500040 ↗
40. 10.1016/j.chempr.2019.05.02310.1016/j.chempr.2019.05.023 ↗
41. 10.1038/s41427-019-0164-410.1038/s41427-019-0164-4 ↗
42. 10.1002/glia.2392610.1002/glia.23926 ↗
43. 10.1002/advs.20230428410.1002/advs.202304284 ↗
44. 10.1016/j.freeradbiomed.2013.07.02410.1016/j.freeradbiomed.2013.07.024 ↗
45. 10.1016/j.tranon.2020.10090510.1016/j.tranon.2020.100905 ↗
46. 10.1155/2021/667057910.1155/2021/6670579 ↗
47. 10.1016/j.radonc.2021.02.00710.1016/j.radonc.2021.02.007 ↗
48. 10.1038/s41590-019-0561-410.1038/s41590-019-0561-4 ↗
49. 10.1016/j.brainres.2022.14793710.1016/j.brainres.2022.147937 ↗
50. 10.1155/2020/435638610.1155/2020/4356386 ↗
51. 10.1038/s41467-020-20275-010.1038/s41467-020-20275-0 ↗
52. 10.1126/sciadv.abk121010.1126/sciadv.abk1210 ↗
53. 10.1016/j.jneumeth.2016.06.01810.1016/j.jneumeth.2016.06.018 ↗
54. 10.1016/j.jconrel.2020.04.03610.1016/j.jconrel.2020.04.036 ↗
55. 10.1016/j.neuint.2018.03.00210.1016/j.neuint.2018.03.002 ↗
56. 10.1126/sciadv.abd688910.1126/sciadv.abd6889 ↗
57. 10.1186/s12974-021-02274-010.1186/s12974-021-02274-0 ↗
58. 10.1016/j.bbi.2021.08.21210.1016/j.bbi.2021.08.212 ↗
59. 10.1016/j.neuint.2022.10546310.1016/j.neuint.2022.105463 ↗
60. 10.1002/cpz1.7001910.1002/cpz1.70019 ↗
61. 10.1126/sciadv.abc703110.1126/sciadv.abc7031 ↗